Groups
Index
Countries
Reset

Dr Leanna Read

CRC for Cell Therapy Manufacturing
Managing Director and Chair 
Your interests

Cell therapy manufacturing and therapeutic development

Company growth strategies

CRC management issues

Dr Tifelle Reisinger United Kingdom

Domainex is a fully integrated drug discovery service company based near Cambridge, UK serving pharmaceutical, biotechnology, academic and patient foundations globally.  Domainex’s drug discovery service business was established in 2001 and since that time has continued to expand to serve a wider range of clients across the world including Auspherix, UCB, FORMA Therapeutics, St George’s University and The Institute of Cancer Research.  Our expertise and commitment to providing high quality services has resulted in a strong success record in drug discovery, delivering an average one candidate drug every year for the past six years.

Domainex’s highly experienced molecular biologists, assay biologists, medicinal, computational and analytical chemists can be leveraged through our CRO services.  Domainex’s focus is on providing highly efficient and well considered scientific solutions to enable successful drug discovery programmes against a wide range of drug targets.  Whether your project is at an early stage of drug discovery or has already identified chemical matter, our processes have been shown to result in a 30% time-saving compared to industry standards and use less resource, allowing prudent management of your own budget.

Website:
http://www.domainex.co.uk/
Domainex
Head of Business Development, Asia Pacific 
Your interests

Domainex offers a one-stop-shop service to meet all your drug discovery needs, from target to candidate. This includes:

- Domainex's platform technologies

- Combinatorial Domain Hunting (CDH)

- protein expression and purification

- biochemical assay development

- cell biology, including mode of action studies

- hit identification, using virtual or fragment-based approaches

- computational chemistry

- medicinal chemistry

- DMPK analysis

Domainex's focus is on providing a highly efficient and well considered scientific solution to enable successful drug discovery programmes against a wide range of drug targets (kinases, protein-protein interactions, GPCR, epigenetic, phenotypic...) in various therapeutic areas (oncology, anti-infectives, inflammation, cardiovascular diseases...).

I would be happy to discuss how Domainex can support your drug discovery programme.

Mr Mike Ridout

Food Agility CRC
Innovation Broker 
Your interests
Agribusiness

Dr Craig Rogers

DST Group
A/Director Industry Engagement 
Your interests

DST Group is seeking opportunities to engage in collaborative research projects in the area of Defence. General areas in Defence we are looking to collaborate in include:

1. Sensors & hypersonics
2. Cyber
3. Medical Countermeasure
4. Quantum Technologies
5. Space Capabilities
6. Human Performance
7. Surveillance
8. Autonomous Systems
9. Material Sciences

As well as in our traditional domains of Maritime, Aerospace, Land.

Mr Keith Russell

Australian National Data Service
Partnerships Programs Manager 
Your interests
The Australian National Data Service is a commonwealth funded project that works with institutions and research organisations around Australia to gain more value out of the data that their researchers produce. We are interested in how you can get a greater impact from the data that your CRC produces and how you can better expose your work or build collaboration around these data assets.

Ms Clare Russell

Ms Clare Russell
RMIT University
LinkedIn logo Senior Advisor, Research Initiatives 
Your interests

I am responsible RMIT’s participation in national research initiatives - with particular focus on CRCs and CRC-Ps. Our team lead and facilitate consortia management throughout bidding and establishment to meet the needs and priorities of our industry partners. I look forward to meeting delegates who are keen to learn more about RMIT’s capability, our team’s role for the university and our partners, and if you are looking to collaborate.